Aldebaran Therapeutics
Waltham, US · Founded 2022 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
LM
Lauren MifflinDirector
CP
Chris PachecoDirector
CL
Carlos LoyaExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$800KraisedMar 2022 · 20 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Lauren MifflinDirector
- Chris PachecoDirector
- Carlos LoyaExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $800K
- Proceeds to insiders
- $150K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.